375 related articles for article (PubMed ID: 15902973)
1. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
[TBL] [Abstract][Full Text] [Related]
2. p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients.
Monti P; Inga A; Aprile A; Campomenosi P; Menichini P; Ottaggio L; Viaggi S; Ghigliotti G; Abbondandolo A; Fronza G
Mutagenesis; 2000 Mar; 15(2):127-32. PubMed ID: 10719037
[TBL] [Abstract][Full Text] [Related]
3. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Kerl H; Wolf P
Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
[TBL] [Abstract][Full Text] [Related]
4. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation.
Dunnick JK; Forbes PD; Eustis SL; Hardisty JF; Goodman DG
Fundam Appl Toxicol; 1991 Jan; 16(1):92-102. PubMed ID: 2019354
[TBL] [Abstract][Full Text] [Related]
5. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
[TBL] [Abstract][Full Text] [Related]
6. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
Nataraj AJ; Wolf P; Cerroni L; Ananthaswamy HN
J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
8. Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers.
Nataraj AJ; Black HS; Ananthaswamy HN
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7961-5. PubMed ID: 8755585
[TBL] [Abstract][Full Text] [Related]
9. Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice.
Kramata P; Lu YP; Lou YR; Singh RN; Kwon SM; Conney AH
Cancer Res; 2005 May; 65(9):3577-85. PubMed ID: 15867351
[TBL] [Abstract][Full Text] [Related]
10. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
11. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
12. Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin.
Wang Y; Gao D; Atencio DP; Perez E; Saladi R; Moore J; Guevara D; Rosenstein BS; Lebwohl M; Wei H
Int J Cancer; 2005 Aug; 116(2):193-9. PubMed ID: 15800929
[TBL] [Abstract][Full Text] [Related]
13. Biological consequences of 8-methoxypsoralen-photoinduced lesions: sequence-specificity of mutations and preponderance of T to C and T to a mutations.
Besaratinia A; Pfeifer GP
J Invest Dermatol; 2004 Dec; 123(6):1140-6. PubMed ID: 15610526
[TBL] [Abstract][Full Text] [Related]
14. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
Wolf P; Kreimer-Erlacher H; Seidl H; Bäck B; Soyer HP; Kerl H
J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
[TBL] [Abstract][Full Text] [Related]
15. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA.
Wang XM; McNiff JM; Klump V; Asgari M; Gasparro FP
Photochem Photobiol; 1997 Aug; 66(2):294-9. PubMed ID: 9277151
[TBL] [Abstract][Full Text] [Related]
16. Fractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressing.
van de Glind G; Rebel H; van Kempen M; Tensen K; de Gruijl F
Oncotarget; 2016 Feb; 7(7):8067-77. PubMed ID: 26797757
[TBL] [Abstract][Full Text] [Related]
17. Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors.
Liu Q; Wang Y; Crist KA; Wang ZY; Lou YR; Huang MT; Conney AH; You M
Carcinogenesis; 1998 Jul; 19(7):1257-62. PubMed ID: 9683186
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
Granstein RD; Morison WL; Kripke ML
Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):198-202. PubMed ID: 1342188
[TBL] [Abstract][Full Text] [Related]
19. Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin.
Zhao JF; Zhang YJ; Jin XH; Athar M; Santella RM; Bickers DR; Wang ZY
J Invest Dermatol; 1999 Dec; 113(6):1070-5. PubMed ID: 10594754
[TBL] [Abstract][Full Text] [Related]
20. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
Tong Y; Smith MA; Tucker SB
J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
